Description: Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The goal of this approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen.
Home Page: comeralifesciences.com
CMRA Technical Analysis
12 Gill Street
Woburn,
MA
01801
United States
Phone:
617 871 2101
Officers
| Name | Title |
|---|---|
| Mr. Jeffrey S. Hackman | Chairman, Pres & CEO |
| Dr. David Soane Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Dr. Neal I. Muni M.D., MSPH | Exec. VP & COO |
| Dr. Robert P. Mahoney Ph.D. | Chief Scientific Officer |
| Mr. Michael G. Campbell CPA | Exec. VP & CFO |
| Ms. Janice Marie McCourt B.S., CLP, M.B.A., R.Ph. | Chief Bus. Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 43.2823 |
| IPO Date: | 2022-05-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 11 |